These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9215740

  • 1. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.
    Martineau D, Klump WM, McCormack JE, DePolo NJ, Kamantigue E, Petrowski M, Hanlon J, Jolly DJ, Mento SJ, Sajjadi N.
    Hum Gene Ther; 1997 Jul 01; 8(10):1231-41. PubMed ID: 9215740
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors.
    Wilson CA, Ng TH, Miller AE.
    Hum Gene Ther; 1997 May 01; 8(7):869-74. PubMed ID: 9143913
    [Abstract] [Full Text] [Related]

  • 3. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
    Kim S, Park EJ, Yu SS, Kim S.
    J Virol Methods; 2004 Jun 01; 118(1):1-7. PubMed ID: 15158062
    [Abstract] [Full Text] [Related]

  • 4. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells.
    Long Z, Li LP, Grooms T, Lockey C, Nader K, Mychkovsky I, Mueller S, Burimski I, Ryan P, Kikuchi G, Ennist D, Marcus S, Otto E, McGarrity G.
    Hum Gene Ther; 1998 May 20; 9(8):1165-72. PubMed ID: 9625255
    [Abstract] [Full Text] [Related]

  • 5. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS, Han E, Hong Y, Lee JT, Kim S, Kim S.
    Gene Ther; 2003 Apr 20; 10(8):706-11. PubMed ID: 12692599
    [Abstract] [Full Text] [Related]

  • 6. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
    Chen J, Reeves L, Cornetta K.
    Hum Gene Ther; 2001 Jan 01; 12(1):61-70. PubMed ID: 11177543
    [Abstract] [Full Text] [Related]

  • 7. Endogenous murine leukemia virus DNA sequences in murine cell lines: implications for gene therapy safety testing by PCR.
    Allan DS, De Koven A, Wild A, Kamel-Reid S, Dubé ID.
    Leuk Lymphoma; 1996 Oct 01; 23(3-4):375-81. PubMed ID: 9031120
    [Abstract] [Full Text] [Related]

  • 8. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
    Patience C, Takeuchi Y, Cosset FL, Weiss RA.
    J Virol; 1998 Apr 01; 72(4):2671-6. PubMed ID: 9525584
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E, Jones-Trower A, Vanin EF, Stambaugh K, Mueller SN, Anderson WF, McGarrity GJ.
    Hum Gene Ther; 1994 May 01; 5(5):567-75. PubMed ID: 8054374
    [Abstract] [Full Text] [Related]

  • 10. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [Abstract] [Full Text] [Related]

  • 11. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
    Garrett E, Miller AR, Goldman JM, Apperley JF, Melo JV.
    Virology; 2000 Jan 05; 266(1):170-9. PubMed ID: 10612671
    [Abstract] [Full Text] [Related]

  • 12. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K.
    Virology; 2001 Mar 30; 282(1):186-97. PubMed ID: 11259201
    [Abstract] [Full Text] [Related]

  • 13. Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.
    Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N.
    Gene Ther; 1995 Mar 30; 2(2):143-50. PubMed ID: 7719931
    [Abstract] [Full Text] [Related]

  • 14. Detection of replication competent retrovirus and lentivirus.
    Sastry L, Cornetta K.
    Methods Mol Biol; 2009 Mar 30; 506():243-63. PubMed ID: 19110631
    [Abstract] [Full Text] [Related]

  • 15. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
    Uchida E, Sato K, Iwata A, Ishii-Watabe A, Mizuguchi H, Hikata M, Murata M, Yamaguchi T, Hayakawa T.
    Biologicals; 2004 Sep 30; 32(3):139-46. PubMed ID: 15536044
    [Abstract] [Full Text] [Related]

  • 16. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C, Klatzmann D, Logg CR, Kasahara N.
    Curr Gene Ther; 2005 Dec 30; 5(6):655-67. PubMed ID: 16457654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS, Kim JM, Kim S.
    Gene Ther; 2000 May 30; 7(9):797-804. PubMed ID: 10822307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.